Bayer Aktiengesellschaft (ETR:BAYN)

Market Cap	32.72B
Revenue (ttm)	45.87B
Net Income (ttm)	-198.00M
Shares Out	982.42M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	8.80
Dividend	0.11 (0.33%)
Ex-Dividend Date	Apr 28, 2025

Volume	2,130,870
Average Volume	3,731,616
Open	33.75
Previous Close	33.58
Day's Range	33.26 - 33.92
52-Week Range	18.38 - 35.02
Beta	0.83
RSI	69.06
Earnings Date	Nov 12, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1863
• Employees: 91,864
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: BAYN

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.